• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structural and functional relationships between h- and l-caldesmons.

作者信息

Hayashi K, Fujio Y, Kato I, Sobue K

机构信息

Department of Neurochemistry and Neuropharmacology, Osaka University Medical School, Japan.

出版信息

J Biol Chem. 1991 Jan 5;266(1):355-61.

PMID:1824698
Abstract

Two different Mr forms of caldesmon as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Mr values in the range of 120,000-150,000, h-caldesmon and 70,000-80,000, l-caldesmon) have been already identified. h-Caldesmon is predominantly expressed in smooth muscle cells, whereas l-caldesmon widely distributes in non-muscle cells. Most recently, the molecular cloning of h-caldesmon has been reported (Hayashi, K., Kanda, K., Kimizuka, F., Kato, I., and Sobue, K. (1989) Biochem. Biophys. Res. Commun. 164, 503-511; Bryan, J., Imai, M., Lee, R., Moore, P., Cook, R. G., and Lin, W-G. (1989) J. Biol. Chem. 264, 13873-13879). The calculated Mr of this protein from its primary structure is 88,743. Here, the nucleotide and deduced amino acid sequences of l-caldesmon have been determined by cloning and sequencing the cDNA from chick brain and compared with those of h-caldesmon. The l-caldesmon cDNA encodes a sequence of 517 amino acids with the calculated Mr of 58,844. Two isoforms of caldesmon conserve the completely identical sequences in the NH2- and COOH-terminal domains except for the insertion of Ala-508 in l-caldesmon. Interestingly, the central repeating sequence of h-caldesmon (residues 201-447) is deleted in the l-caldesmon molecule. The short NH2-terminals of two caldesmons individually show the unique sequences. The results of Northern and Southern blot analyses suggest that two mRNAs (4.8 and 4.1 kilo-bases) coding for caldesmon isoforms may be generated from a single gene by alternative splicing. Using a series of truncated caldesmons expressed in Escherichia coli, the common calmodulin-, tropomyosin-, and actin-binding sites and the minimum regulatory domains, which are involved in the Ca2(+)-dependent regulation of actin-myosin interaction, have been identified within the limited consensus sequences (residues 381-433 for l-caldesmon and residues 636-688 for h-caldesmon).

摘要

相似文献

1
Structural and functional relationships between h- and l-caldesmons.
J Biol Chem. 1991 Jan 5;266(1):355-61.
2
Primary structure and functional expression of h-caldesmon complementary DNA.人钙调蛋白互补DNA的一级结构与功能表达
Biochem Biophys Res Commun. 1989 Oct 16;164(1):503-11. doi: 10.1016/0006-291x(89)91748-8.
3
Cloning and expression of a smooth muscle caldesmon.
J Biol Chem. 1989 Aug 15;264(23):13873-9.
4
Characterization of the carboxyl-terminal 10-kDa cyanogen bromide fragment of caldesmon as an actin-calmodulin-binding region.钙调蛋白羧基末端10 kDa溴化氰片段作为肌动蛋白 - 钙调蛋白结合区域的特性研究
J Biol Chem. 1990 Sep 5;265(25):15231-8.
5
Vascular smooth muscle caldesmon.血管平滑肌钙调蛋白
J Biol Chem. 1986 Jun 15;261(17):8028-35.
6
Location of smooth-muscle myosin and tropomyosin binding sites in the C-terminal 288 residues of human caldesmon.平滑肌肌球蛋白和原肌球蛋白结合位点在人钙调蛋白C末端288个残基中的定位。
Biochem J. 1995 Dec 1;312 ( Pt 2)(Pt 2):617-25. doi: 10.1042/bj3120617.
7
Caldesmon has two calmodulin-binding domains.钙调蛋白有两个钙调素结合结构域。
Biochem Biophys Res Commun. 1989 Jul 31;162(2):746-52. doi: 10.1016/0006-291x(89)92373-5.
8
Alignment of caldesmon on the actin-tropomyosin filaments.钙调蛋白在肌动蛋白-原肌球蛋白丝上的排列。
Biochem J. 1995 Aug 1;309 ( Pt 3)(Pt 3):951-7. doi: 10.1042/bj3090951.
9
Cloning of cDNAs encoding human caldesmons.编码人钙调蛋白的cDNA的克隆
Gene. 1992 Mar 15;112(2):197-204. doi: 10.1016/0378-1119(92)90376-z.
10
Caldesmon: fragments, sequence, and domain mapping.钙调蛋白:片段、序列及结构域定位
Ann N Y Acad Sci. 1990;599:100-10. doi: 10.1111/j.1749-6632.1990.tb42368.x.

引用本文的文献

1
Myocardin regulates exon usage in smooth muscle cells through induction of splicing regulatory factors.肌球蛋白调节蛋白通过诱导剪接调控因子调节平滑肌细胞外显子的使用。
Cell Mol Life Sci. 2022 Aug 1;79(8):459. doi: 10.1007/s00018-022-04497-7.
2
Caldesmon: Biochemical and Clinical Implications in Cancer.钙调蛋白:在癌症中的生化及临床意义
Front Cell Dev Biol. 2021 Feb 18;9:634759. doi: 10.3389/fcell.2021.634759. eCollection 2021.
3
Caldesmon regulates axon extension through interaction with myosin II.钙调蛋白通过与肌球蛋白 II 的相互作用调节轴突延伸。
J Biol Chem. 2012 Jan 27;287(5):3349-56. doi: 10.1074/jbc.M111.295618. Epub 2011 Dec 9.
4
Diversification of caldesmon-linked actin cytoskeleton in cell motility.钙调蛋白连接的肌动蛋白细胞骨架在细胞运动中的多样化。
Cell Adh Migr. 2011 Mar-Apr;5(2):150-9. doi: 10.4161/cam.5.2.14398. Epub 2011 Mar 1.
5
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.收缩型平滑肌细胞表型的分子调控:对血管组织工程的启示。
Tissue Eng Part B Rev. 2010 Oct;16(5):467-91. doi: 10.1089/ten.TEB.2009.0630.
6
Caldesmon as a therapeutic target for proliferative vascular diseases.钙调蛋白作为增殖性血管疾病的治疗靶点。
Mini Rev Med Chem. 2008 Oct;8(12):1209-13. doi: 10.2174/138955708786140981.
7
Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2.嵌套基因DDC8与其宿主基因金属蛋白酶组织抑制剂-2之间潜在的调控关系。
Physiol Genomics. 2007 Jan 17;28(2):168-78. doi: 10.1152/physiolgenomics.00160.2006. Epub 2006 Sep 19.
8
Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.钙调蛋白(CaP)作为一种闩桥蛋白——平滑肌收缩调节的新概念。
J Muscle Res Cell Motil. 2004;25(1):7-19. doi: 10.1023/b:jure.0000021349.47697.bf.
9
Smooth muscle proteins as intracellular components of the chromatophores of the Antarctic fishes Pagothenia borchgrevinki and Trematomus bernacchii (Nototheniidae).平滑肌蛋白作为南极鱼类巴氏南极鱼和伯氏南极鱼(南极鱼科)色素细胞的细胞内成分。
Protoplasma. 2001;218(1-2):24-30. doi: 10.1007/BF01288357.
10
Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells.磷酸肌醇3激酶/蛋白激酶B(Akt)与丝裂原活化蛋白激酶(ERK/p38MAPK)平衡的改变决定了内脏和血管平滑肌细胞的表型。
J Cell Biol. 1999 May 17;145(4):727-40. doi: 10.1083/jcb.145.4.727.